down arrow

Colinz Labs

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE923C01011
  • NSEID:
  • BSEID: 531210
INR
48.08
-2.53 (-5.0%)
BSENSE

Apr 11, 12:37 PM

BSE+NSE Vol: 1.84 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Colinz Laboratories Ltd stock-summary
stock-summary
Colinz Laboratories Ltd
Micro Cap
Pharmaceuticals & Drugs
Colinz Laboratories Limited, was incorporated as a Private Limited Company in 1986. The Company got converted into Public Limited Company in 1995, which however started their manufacturing and marketing activities in 1995. The Company manufactures a wide variety of pharmaceutical formulations in the dosage forms of tablets, capsules, granules, liquid orals, injectables, ointments, creams etc. The Company is having certain specialized products for Gynaecology, Cardiology, Gastroentrology etc.
Company Coordinates stock-summary
Company Details
A-101 Pratik Industrial Estate, Mulund Goregaon Link Road Mumbai Maharashtra : 400078
stock-summary
Tel: 91-022-25668002/8003
stock-summary
colinzlabs@yahoo.com
Registrar Details
Bigshare Services Pvt Ltd , E-2 , Ansa Industrial Estate, Saki Vihar Road, Saki Naka, Andheri (E), Mumbai
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR None Cr
Number of Shares
None Cr
Face Value
INR None
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Mani L S (34.45%)

Highest Public shareholder

Dipakbhai Haribhai Gaudani (1.31%)

Individual Investors Holdings

31.01%

stock-summary Board of Directors
stock-summary
stock-summary
Management
Designation
Remuneration
L S Mani
Director & Company Secretary
16.45 lacs
N K Menon
Whole-time Director
13.93 lacs
Vasant K Bhat
Independent Director
50.0 k
A Krishna Kumar
Independent Director
50.0 k
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
 
Icon
No Data Available
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Pharmaceutical Formulations
7.96
100.00%
 
100
Pharmaceutical Formulations
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
1 Cr
(Quarterly Results - Dec 2024)
Net Profit:
0 Cr
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 22 Cr (Micro Cap)

stock-summary
P/E

23.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.77

stock-summary
Return on Equity

5.24%

stock-summary
Price to Book

2.47